The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/30161
StudyName: Eligibility Leukemia NCT00362466
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 16.05.2018
License: Creative Commons BY 4.0

----

Description: 
A Study of Dasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00362466
